18F-FDG PET/CT Scans Can Identify Sub-Groups of NSCLC Patients with High Glucose Uptake in the Majority of Their Tumor Lesions
Conclusions: 18F-FDG PET/CT scans can identify sub-groups of NSCLC patients with high glucose uptake in the majority of their tumor lesions. T2DM patients had higher tumor lesion glucose uptake than non-diabetic patients. However, this was not independent of other factors such as the histological subtype and number of tumor lesions per patient.
Source: Journal of Cancer - Category: Cancer & Oncology Authors: Anne M. Hendriks, Adrienne H. Brouwers, Panagiotis Giannopoulos, Joop D. Lefrandt, Wim Timens, Harry J.M. Groen, Geertruida H. de Bock, Mathilde Jalving Tags: Research Paper Source Type: research
More News: Cancer | Cancer & Oncology | CT Scan | Diabetes | Diabetes Mellitus | Diabetes Type 2 | Endocrinology | Lung Cancer | Non-Small Cell Lung Cancer | Nuclear Medicine | PET Scan